ArticleUnited European gastroenterology journal2021

Infliximab clearance decreases in the second and third trimesters of pregnancy in inflammatory bowel disease.

Ana-Marija Grišić et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.